Two hits are better than one: rational dual strategy efficiently fights neuroblastoma
Signal Transduct Target Ther
.
2024 Apr 30;9(1):116.
doi: 10.1038/s41392-024-01827-y.
Authors
Jacques Zimmer
1
,
Camille Rolin
2
3
,
Markus Ollert
2
4
Affiliations
1
Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg. Jacques.Zimmer@lih.lu.
2
Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
3
University of Luxembourg, Esch-sur-Alzette, Luxembourg.
4
Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), University of Southern Denmark, Odense, Denmark.
PMID:
38688910
PMCID:
PMC11061121
DOI:
10.1038/s41392-024-01827-y
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Neuroblastoma* / drug therapy
Neuroblastoma* / genetics
Neuroblastoma* / pathology
Grants and funding
DTU i2TRON, PRIDE19/14254520/Fonds National de la Recherche Luxembourg (National Research Fund)